medigraphic.com
ISSN 1561-2929 (Print)

2012, Number 1

<< Back Next >>

RCAN 2012; 22 (1)

Impact of vitamin-mineral supplementation within a body weight reduction protocol

Barceló AM, Borroto DG

Language: Spanish
References: 22
Page: 98-110
PDF size: 193.82 Kb.


ABSTRACT

The impact of vitamin-mineral supplementation within a body weight reduction protocol was assessed by means of a quasi-experimental trial with 120 overweight patients (Women: 83.3%, Age: 38 ± 5 years; Body Mass Index: 34.0 ± 2.5Kg.m-2) assisted at the Clinic for the Treatment of Obesity of the “Hermanos Ameijeiras” Clinical Surgical Hospital (Havana City, Cuba) who consented with it. Vitaminmineral supplementation comprised the intake of 2 preparations: FastTabs®© (100% of the dietetic recommendations for the North American population in 15 different vitamins and minerals); and VitaTabs®© (50% of the recommendations). Treated patients received 6 courses of vitamin-mineral supplementation: At admission, At 30 days, 60 days, 90 days, 180 days, and 365 days, respectively; superimposed upon the current body weight reduction protocol comprising energy restriction, physical exercise, emotional support and health promotion and education activities. The design of each course was as follows: Day 1: FastTabs®©: 1 tablet taken with water (8 ounces) every hour after the 13:00 hours up until completing 8 units; and Day 2: VitaTabs®©: 1 tablet every 8 hours up until completing 3 units, in each of the 3 meals of the day. Once supplementation was concluded, reduction of body weight and the size of body fat, along with diminishment of fasting serum glucose, total cholesterol, and triglycerides were found. Changes observed in anthropometric and biochemical indicators were significantly higher in the supplemented patients. These results show the effectiveness of vitamin-mineral supplementation within a body weight reduction protocol aimed to prevent micronutrients deficiencies during food restriction.


REFERENCES

  1. Yates EA, Macpherson AK, Kuk JL. Secular trends in the diagnosis and treatment of obesity among US adults in the primary care setting. Obesity 2011; 10:1234-9.

  2. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378(97):815-25.

  3. Rosenbaun M, Liehel RL, Ilirsh J. Obesity. N Engl J Med 2001;337: 396-97.

  4. Meires J, Christie C. Contemporary approaches to adult Obesity treatment Nurse Pract 2011;36:37-46.

  5. O'Gorman DJ, Krook A. Exercise and the treatment of diabetes and obesity. Med Clin North Am 2011;95:953-69.

  6. Van Dorsten B, Lindley EM. Cognitive and behavioral approaches in the treatment of obesity. Med Clin North Am 2011;95:971-88.

  7. Ocaña del Río NE. Algunas características clínicas y bioquímicas del paciente obeso. Trabajo de Terminación de Residencia en Endocrinología. Hospital Clínico Quirúrgico “Hermanos Ameijeiras”. La Habana: 1991.

  8. Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasiexperimental designs for evaluating guideline implementation strategies. Family Practice 2000;17:S11–S18.

  9. Weiner JA, Lourie JA. Practical Human Biology. Academic Press. London: 1981.

  10. Lohman TG, Roche A, Martorell R. Anthropometric standardization reference manual. Human Kinetics Books. Primera Edición. Champaign, Illinois: 1988.

  11. Gorstein J, Sullivan K, Yip R, de Onis M, Trowbridge F, Fajans P y cols. Issues in the assessment of nutritional status using anthropometry. Bulletin of the World Health Organization 1994; 72:273-83.

  12. Weltman A, Seip RL, Vu Tran Z. Practical assessment of body composition in adult obese females. Human Biol 1987;59:523-35.

  13. Weltman A, Levine S, Seip RL, Vu Tran Z. Accurate assessment of body composition in obese females. Am J Clin Nutr 1988;48:1179-83.

  14. Martínez Canalejo H, Santana Porbén S. Manual de Procedimientos Bioestadísticos. Editorial Ciencias Médicas. La Habana: 1990.

  15. Martínez de Morentín BE, Rodríguez MC, Martínez JA. Síndrome metabólico, resistencia a la insulina y metabolismo tisular. Endocrinol Nutr 2003;50:324-33.

  16. Cho LW. Metabolic syndrome. Singapore Med J 2011;52:779-85.

  17. Raal FJ. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord 2009;7:83-8.

  18. Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 2010;1: 68-75.

  19. Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL. The biology of human starvation Minneapolis: University of Minnesota Press; 1950.

  20. Webter J D, Hespe R, Garrow I. Recomposition of excess weight in obese woman estimated by body density, total body water and total body potassium. Clin Nutr 2002;38:299-307.

  21. Anónimo. Niacin: its value in raising HDL cholesterol is being questioned. Heart Advis 2011;14:7.

  22. Anónimo. Trial clouds use of niacin with a statin. Harv Heart Lett 2011;21:2.




2020     |     www.medigraphic.com